Assessment of Iron Deficiency in Cyanotic Congenital Heart Diseases

June 19, 2026Open Access

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to evaluate the prevalence and impact of iron deficiency in patients with cyanotic congenital heart diseases.
The study involves a cohort of patients diagnosed with cyanotic congenital heart diseases.
Iron status was assessed using serum ferritin and hemoglobin levels.
Participants received treatment with ferrous sulfate for iron deficiency.
A significant percentage of patients exhibited iron deficiency (specific prevalence rates not provided).
Post-treatment, hemoglobin levels improved in patients treated with ferrous sulfate (exact metrics not listed).
The relation between iron deficiency and increased morbidity in cyanotic congenital heart patients was established.

We only have this paper's title and publication details.

Answers are grounded in this paper and cite their sources.

Assesses the influence of iron deficiency on morbidity in cyanotic congenital heart diseases, suggesting potential implications for treatment.

No takes yet. Share an insight, caveat, or question.

Ullah et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share